Ascletis Pharma (china) Co., Limited

This study tested a new tablet called ASC30 to help people who are overweight or obese and have related health problems lose weight. About 125 adults took either the study drug or a placebo for 13 weeks. Researchers measured weight loss, waist size, and safety to see if the drug …

This early-stage study tested whether adding an experimental injection called ASC47 to the weight-loss drug semaglutide is safe and helps with weight management. 28 adults with obesity received either the combination or a placebo. Researchers measured side effects and weight chan…